ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

THE VIABILITY OF THE NEW STRATEGY IN PATIENTS SUFFERING FROM DISORDERS OF LUMBAR CHARACTERISTICS

AUTHORS:

Muhammad Usman Faryad Khan, Dr. Hoorab Saeed, Dr. Wajiha Ahmad

ABSTRACT:

Objective: Radiofrequency Thermocoagulation is the generally new method and was proposed for the cure of back agony analyzed from the joints of the spine. We wanted to evaluate the viability of this new strategy in our patients suffering from disorders of lumbar characteristics in our Algology Division. Methods: In this review, the observational investigation, the restoration records of 498 patients with lumbar aspect disorders treated with RFT in 2017-2019, were verified. Altogether information was gained from torment assessment sheets in patients' documents and noted. Information on age, gender, scores on the Simple Visual Scale (SVS) when treated and post-treatment achievement scores were recorded from the patients' treatment records. Torment scores on the Simple Visual Scale (SVA), daily exercises (1= poor to 4 = generally excellent) and achievement scores (1= poor to 4 = phenomenal) before the technique and on Day 1, Day 2, and subsequently at several weeks, 2 weeks, one month, half a year and one year after the strategy remained studied and noted. Results: The average VAS score before treatment was 9.04 ± 2.07, one month after treatment it was basically decreased and one and a half year after treatment it was 2.19 ± 0.77. Achievement scores were found to be substantially higher after treatment. Developmental scores were found higher after treatment than before treatment. No entanglement was noted in any of patients. Conclusion: Authors believe that radio recurrence thermocoagulation can lead to a substantial longstanding enhancement in lumbar agony, and may recover physical capacity to the larger degree in cases having appearance disorders. Key words: Facet disease; Low back agony; Pain dimension; Radiofrequency thermocoagulation; VAS.

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.